Eczema Free Forever™ Eczema Free Forever™

The next fundraising challenge for SIX TIMES OPEN

Three Peaks Challenge
SIX TIMES OPEN, a fundraising campaign led by fraternal twins, Jonathan and David Stretton-Downes, have been working hard to reach their goal of raising £100,000 in one year for the British Heart Foundation’s research into heart disease. They have taken on some weird and wacky challenges, but their latest challenge is guaranteed to blow the rest out of the water.

On April 7th, a select group of SIX TIMES OPEN challengers will be taking part in the Three Peaks Challenge – which will see them climbing the 3 highest peaks in Wales, Scotland and England, in under 24 hours. The challenger group is made up on men and women who have a personal connection to heart disease. If that wasn’t enough, they will also be getting their heads shaved at the highest point on Ben Nevis, a hair-raising 4412ft high.

Their hair-brained scheme is being supported by award winning hairdressers, Jones and Payne, who will be joining the SIX TIMES OPEN challengers on their trek up Ben Nevis.

The SIX TIMES OPEN campaign began in November 2016, while Jonathan was awaiting his sixth heart surgery. Since then, the brothers have raised a staggering £25,000 for the British Heart Foundation, which has gone into lifesaving research on heart disease.

The team are aiming to raise a further £3,000 in donations, taking their fundraising efforts to around £30,000. This isn’t all SIX TIMES OPEN has planned in, you can take a look at further fundraising events below:

6-7th April 2018 – 3 Peaks Challenge
18th May 2018 – The TICKER BALL – SAVOY
20th May 2018 – The TENPAST Challenge Cup – Charity Football Match at the Stadium of Light

The post The next fundraising challenge for SIX TIMES OPEN appeared first on talkhealth Blog.

talkhealth Blog

Buoyed by new eczema data, AnaptysBio hits the fundraising button – FierceBiotech


FierceBiotech
Buoyed by new eczema data, AnaptysBio hits the fundraising button
FierceBiotech
After a single dose of ANB020, 75% of the 12 enrolled patients achieved an Eczema Area Severity Index score improvement of 50% (EASI-50) or more at day 15, 83% of patients at day 29 and 75% of patients achieved EASI-50 after 57 days or around two …
AnaptysBio Could Rival Regeneron Pharmaceuticals, Sanofi In …Investor’s Business Daily
Here's Why AnaptysBio Inc. Is Rocketing Higher TodayMotley Fool

all 70 news articles »

eczema – Google News

Buoyed by new eczema data, AnaptysBio hits the fundraising button – FierceBiotech


FierceBiotech
Buoyed by new eczema data, AnaptysBio hits the fundraising button
FierceBiotech
After a single dose of ANB020, 75% of the 12 enrolled patients achieved an Eczema Area Severity Index score improvement of 50% (EASI-50) or more at day 15, 83% of patients at day 29 and 75% of patients achieved EASI-50 after 57 days or around two …
AnaptysBio Could Rival Regeneron Pharmaceuticals, Sanofi In …Investor’s Business Daily

all 70 news articles »

eczema – Google News

Buoyed by new eczema data, AnaptysBio hits the fundraising button – FierceBiotech


FierceBiotech
Buoyed by new eczema data, AnaptysBio hits the fundraising button
FierceBiotech
After a single dose of ANB020, 75% of the 12 enrolled patients achieved an Eczema Area Severity Index score improvement of 50% (EASI-50) or more at day 15, 83% of patients at day 29 and 75% of patients achieved EASI-50 after 57 days or around two …
AnaptysBio Could Rival Regeneron Pharmaceuticals, Sanofi In …Investor’s Business Daily
AnaptysBio Reports Positive Topline Proof-of-Concept Data from Phase 2a Clinical Trial of ANB020 in Atopic DermatitisMarkets Insider

all 70 news articles »

eczema – Google News